Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on October 24, 2002; DOI 10.1182/blood-2002-05-1513.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1513v1
101/5/2024    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rigby, S. M
Right arrow Articles by Field, E. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rigby, S. M
Right arrow Articles by Field, E. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted May 23, 2002
Accepted October 14, 2002

Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4 producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells

Shawn M Rigby, Todd Rouse, and Elizabeth H Field*

Department of Internal Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA, USA
Department of Veterans Affairs Medical Center, Iowa City, IA, USA

* Corresponding author; email: elizabeth-field{at}uiowa.edu.

Preconditioning with the nonmyeloablative regimen total lymphoid irradiation (TLI) prior to hematopoietic cell transplant facilitates the establishment of mixed-chimerism and protects against graft-vs-host-disease. We reported that the development of mixed-chimerism requires IL-4 and is associated with increased host anti-donor Th2 cells, but the effect of TLI on the differentiation of immunocompetent donor cells had not been investigated. To examine the extent to which TLI preconditioning influences donor T cells, we measured responses of OVA-transgenic CD4+ cells (OVA-Tg), following in vivo and in vitro antigen stimulation within a TLI-preconditioned environment. OVA-Tg cells that were adoptively transferred into TLI-preconditioned mice that express cross-reactive antigens produce more IL-4 and less IFN{gamma} and IL-2 than controls when stimulated with OVA-peptide one week later. OVA-Tg primed in vitro with spleen from TLI-preconditioned mice generate more Th2 and less Th1 cells when stimulated in recall ELISPOTs assays with OVA-peptide. Naive OVA-Tg upregulate CD69 and CD25 normally following stimulation with OVA-peptide in the presence of spleen from TLI-preconditioned mice, but proliferate less and secrete less IL-2 than controls. Surprisingly, naive OVA-Tg secrete IL-4 in primary cultures that were stimulated with OVA-peptide in the presence of spleen from TLI-preconditioned mice. This response depends on CD4+ cells from TLI-spleen, which constitutively produce IL-4 and are comprised primarily of CD4+-TNK cells. Thus, TLI-preconditioning enriches for IL-4 secreting and TNK-like CD4+ cells that may function in the protection from graft-vs-host-disease by redirecting the differentiation of immunocompetent donor CD4+ cells towards Th2 and away from pathogenic Th1 cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. B. Pillai, T. I. George, S. Dutt, and S. Strober
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
Blood, April 30, 2009; 113(18): 4458 - 4467.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kashiwada, G. Cattoretti, L. McKeag, T. Rouse, B. M. Showalter, U. Al-Alem, M. Niki, P. P. Pandolfi, E. H. Field, and P. B. Rothman
Downstream of Tyrosine Kinases-1 and Src Homology 2-Containing Inositol 5'-Phosphatase Are Required for Regulation of CD4+CD25+ T Cell Development
J. Immunol., April 1, 2006; 176(7): 3958 - 3965.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Hashimoto, S. Asakura, S. Miyake, T. Yamamura, L. Van Kaer, C. Liu, M. Tanimoto, and T. Teshima
Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells
J. Immunol., January 1, 2005; 174(1): 551 - 556.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020